Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Degarelix Dose-Finding in Prostate Cancer
NCT00818623Phase 2Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Nov 2002
- Primary completion
- Oct 2004
- Modality
- Peptides, Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of degarelix in prostate cancer (PCa), sponsored by Ferring Pharmaceuticals. Started Nov 2002; status: completed.
02
Drugs
degarelix
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00818623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00818623.